26.44

1.07% 0.28

After Hours: 26.80 0.36 +1.36%

Adaptive Biotechnologies Corp (ADPT)

Overview News Price History Option Chain Financials Why ADPT Down? Discussions Forecast

Adaptive Biotechnologies Corp stock is traded at $26.44, with a volume of 2.08M. It is up +1.07% in the last 24 hours and up +17.30% over the past month. Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Previous Close:

$26.16

Open:

$26.23

24h Volume:

2.08M

Relative Volume:

0.72

Market Cap:

$4.22B

Revenue:

$295.41M

Net Income/Loss:

$-49.64M

P/E Ratio:

-80.76

EPS:

-0.3274

Net Cash Flow:

$-29.54M

1W Performance:

+3.93%

1M Performance:

+17.30%

6M Performance:

+65.04%

1Y Performance:

+103.86%

1-Day Range:

$26.11

$26.87

1-Week Range:

$24.93

$26.87

52-Week Range:

$12.00

$26.87

Adaptive Biotechnologies Corp Stock (ADPT) Company Profile

Name

Adaptive Biotechnologies Corp

Sector

Healthcare (1082)

Industry

Diagnostics & Research (50)

Phone

206-659-0067

Address

1165 EASTLAKE AVE E, SEATTLE, WA

Employee

624

Twitter

@adaptivebiotech

Next Earnings Date

2026-07-29

Latest SEC Filings

ADPT's Discussions on Twitter

Compare ADPT vs TMO, DHR, NTRA, A, IQV

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ADPT Adaptive Biotechnologies Corp	26.44	4.06B	295.41M	-49.64M	-29.54M	-0.3274
TMO Thermo Fisher Scientific Inc	630.70	232.03B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	215.68	151.78B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	338.70	46.82B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	157.69	44.14B	7.23B	1.41B	1.09B	4.979
IQV Iqvia Holdings Inc	262.38	42.15B	16.63B	1.39B	2.12B	8.0674

Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-25	Resumed	Morgan Stanley	Equal-Weight
Sep-30-25	Initiated	Guggenheim	Buy
Jun-18-25	Initiated	Craig Hallum	Buy
Mar-21-25	Upgrade	Goldman	Neutral → Buy
Jul-05-23	Resumed	JP Morgan	Overweight
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Dec-21-22	Upgrade	Piper Sandler	Neutral → Overweight
Aug-25-22	Initiated	Credit Suisse	Underperform
Jun-03-22	Initiated	Piper Sandler	Neutral
Feb-16-22	Reiterated	BTIG Research	Buy
Feb-16-22	Reiterated	BofA Securities	Buy
Feb-16-22	Reiterated	Goldman	Neutral
Feb-16-22	Reiterated	JP Morgan	Overweight
Oct-15-21	Resumed	Cowen	Outperform
Mar-03-21	Downgrade	Goldman	Buy → Neutral
Oct-08-20	Resumed	BTIG Research	Buy
Sep-09-20	Initiated	Morgan Stanley	Equal-Weight
Jun-03-20	Initiated	Goldman	Buy
Jul-23-19	Initiated	BTIG Research	Buy
Jul-22-19	Initiated	BofA/Merrill	Buy
Jul-22-19	Initiated	Cowen	Outperform
Jul-22-19	Initiated	Goldman	Neutral
Jul-22-19	Initiated	Guggenheim	Buy
Jul-22-19	Initiated	William Blair	Outperform

View All

Adaptive Biotechnologies Corp Stock (ADPT) Latest News

Aug 21, 2026

Adaptive Biotechnologies Stock Has Doubled in the Past Year. Here’s What Could Come Next. - inkl

Aug 21, 2026

Bank of America Corp DE Acquires 421,645 Shares of Adaptive Biotechnologies Corporation $ADPT - MarketBeat

Aug 21, 2026

Adaptive Biotechnologies director Robert Hershberg sells $748k in shares - Investing.com

Aug 21, 2026

Adaptive Biotechnologies director Robert Hershberg sells $748k in shares By Investing.com - Investing.com South Africa

Aug 21, 2026

Aug 20, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) Director Robert Hershberg Sells 30,664 Shares of Stock - MarketBeat

Aug 20, 2026

Adaptive Biotechnologies Director Robert Hershberg Executes Stock Option and Sells Shares - Kalkine Media

Aug 20, 2026

Adaptive Biotech (NASDAQ: ADPT) ex-officer to sell 402,160 shares - Stock Titan

Aug 20, 2026

Adaptive Biotechnologies (NASDAQ: ADPT) director exercises option at $6.32 strike - Stock Titan

Aug 20, 2026

Aug 19, 2026

Adaptive Biotechnologies director Neupert sells $3.1m in stock By Investing.com - Investing.com Nigeria

Aug 19, 2026

Adaptive Biotechnologies CEO Chad Robins sells $14.88m in shares By Investing.com - Investing.com India

Aug 19, 2026

Adaptive Biotechnologies director Neupert sells $3.1m in stock - Investing.com

Aug 19, 2026

Adaptive Biotechnologies CEO Chad Robins sells $14.88m in shares - Investing.com

Aug 19, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) CEO Chad Robins Sells 278,676 Shares - MarketBeat

Aug 19, 2026

Adaptive Biotechnologies (ADPT) CEO sells 600K shares after exercising options - Stock Titan

Aug 19, 2026

Adaptive Biotechnologies (ADPT) director sells stock after option exercise - Stock Titan

Aug 19, 2026

Adaptive Biotechnologies (NASDAQ: ADPT) ex-officer plans new share sale - Stock Titan

Aug 19, 2026

Adaptive Biotechnologies stock hits 52-week high at 26.16 USD By Investing.com - Investing.com Nigeria

Aug 19, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) Sets New 1-Year HighHere's What Happened - MarketBeat

Aug 19, 2026

Adaptive Biotechnologies stock hits 52-week high at 26.16 USD - Investing.com

Aug 19, 2026

66,000 Shares in Adaptive Biotechnologies Corporation $ADPT Bought by Handelsbanken Fonder AB - MarketBeat

Aug 19, 2026

Aug 18, 2026

Adaptive Biotechnologies (NASDAQ: ADPT) director plans to resell 30,664 shares - Stock Titan

Aug 18, 2026

Adaptive Biotechnologies (NASDAQ: ADPT) insider plans more sales after $7.96M already sold - Stock Titan

Aug 18, 2026

Adaptive Biotechnologies (ADPT) ex-officer plans cashless option share sale - Stock Titan

Aug 18, 2026

Aug 17, 2026

Adaptive Biotech co-founder raises $15M for new startup to rethink how AI trains on science - GeekWire

Aug 17, 2026

Adaptive Biotechnologies (NASDAQ: ADPT) insider plans multimillion stock sale - Stock Titan

Aug 17, 2026

Adaptive Biotechnologies (ADPT) plans multi-million-dollar stock sale for 2026 - Stock Titan

Aug 17, 2026

Adaptive Biotechnologies (NASDAQ: ADPT) lines up six-figure share sale for 2026 - Stock Titan

Aug 17, 2026

Aug 14, 2026

Dimensional Fund Advisors LP Cuts Stock Holdings in Adaptive Biotechnologies Corporation $ADPT - MarketBeat

Aug 14, 2026

Aug 13, 2026

576,266 Shares in Adaptive Biotechnologies Corporation $ADPT Bought by Wasatch Advisors LP - MarketBeat

Aug 13, 2026

Adaptive Biotechnologies (ADPT) Stock Looks Fair On Cash Flow Yet Rich On Sales - simplywall.st

Aug 13, 2026

Aug 12, 2026

Adaptive Biotechnologies CCO Susan Bobulsky sells $75,000 in shares By Investing.com - Investing.com Nigeria

Aug 12, 2026

Adaptive Biotechnologies CCO Susan Bobulsky sells $75,000 in shares - Investing.com

Aug 12, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) Insider Susan Bobulsky Sells 3,000 Shares of Stock - MarketBeat

Aug 12, 2026

Adaptive Biotechnologies (ADPT) CCO Bobulsky sells 3,000 shares under plan - Stock Titan

Aug 12, 2026

Aug 11, 2026